Comparative evaluation of adherence to antiretroviral therapy in sub-Saharan African native HIV-infected patients in France and Africa

Clinical Infectious Diseases

Volumn 43, Issue 5, 2006, Pages 654-657

  Sellier, Pierre ^a,c   Clevenbergh, Philippe ^a   Ljubicic, Liliane ^a   Simoneau, Guy ^a   Evans, John ^b   Delcey, Véronique ^a   Diemer, Myriam ^a   Bendenoun, Marc ^a   Mouly, Stéphane ^a   Bergmann, Jean François ^a  

^a pital Lariboisière   (France)

^b pital Paul Brousse   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; ARTICLE; CONTROLLED STUDY; FAMILY; FEAR; FEMALE; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SOCIAL SUPPORT;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SOCIOECONOMIC FACTORS; TRAVEL;

EID: 33747625887     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/506436     Document Type: Article

References (17)

1. Thierry X. Les entrées d'étrangers en France de 1994 à 1999 [in French]. Population 2001; 56:423-50.
2. Institut de veill sanitaire. Maladies à déclaration obligatoire: infection à VIH et sida. Available at: http://www.invs. sante.fr/surveillance/vih -sida/default.htm. Accessed 25 July 2006.
3. AIDS and HIV in Scotland, 1996: a summary. SCIEH Wkly Rep 1997; 31:33.
4. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30.
5. Lopez-Suarez A, Fernandez-Guttierez del Alamo C, Perez-Guzman E, Giron-Gonzalez JA. Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients. AIDS 1998; 12:685-6.
6. Gordillo V, Del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999; 13:1763-9.
7. Wenger N, Gifford A, Liu H, et al. Prevalence and predictors of HAART use in patients with HIV infection in the United States. J Acquir Immune Defic Syndr 2000; 25:115-23.
8. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. APROCO Cohort Study Group. Soc Sci Med 2002; 54:1481-96.
9. Carrieri P, Cailleton V, Le Moing V, et al. The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. J Acquir Immune Defic Syndr 2001; 28:232-9.
10. Dray-Spira R, Lert F, Marimoutou C, Bouhnik AD, Obadia Y. Socioeconomic conditions, health status and employment among persons living with HIV/AIDS in France in 2001. AIDS Care 2003; 15:739-48.
11. Weidle PJ, Ganea CE, Irwin KL, et al. Adherence to antiretroviral medication in an inner city population. J Acquir Immune Defic Syndr 1999; 22:498-505.
12. Laurent C, Diakhate N, Ngom Gueyc NF, et al. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS 2002; 16:1363-70.
13. Laurent C, Ngom Gueye NF, Ndour CT, et al. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr 2005; 38:14-7.
14. Nachega JB, Stein DM, Lehman DA, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 2004; 20:1053-6.
15. Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 2003; 17:1369-75.
16. Nachega JB, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, Karstaedt AS. HIV/AIDS and antiretroviral treatment knowledge, attitudes, beliefs, and practices in HIV-infected adults in Soweto, South Africa. J Acquir Immune Defic Syndr 2005; 38:196-201.
17. Degefa A, Sanders EJ, Mekonnen Y, et al. Knowledge and attitudes towards antiretroviral therapy among factory workers participating in a cohort on HIV and AIDS, Addis Ababa, Ethiopia. Ethiop Med J 2003; 41:75-87.